In this video, we dive deep into the upcoming IPO of Akums Drugs and Pharmaceuticals Limited, one of India's largest CDMO companies. If you're interested in investing in the pharmaceutical sector,click here: [ Ссылка ]
**Akums Drugs & Pharmaceuticals IPO**
Bidding Dates: 30-1 Aug
Min. Investment: ₹14,212.00
Lot Size: 22 shares
**Akums Drugs & Pharmaceuticals IPO: Key details
1. **Issue Size:** ₹1,856.74 crore
2. **Fresh Issue:** ₹680 crore
3. **Offer for Sale:** ₹1,176.74 crore
4. **Use of Funds:** Capital requirements, debt repayment, and growth initiatives
5. **Products:** Tablets, capsules, eye drops, injections, gummies, and more
6. **Manufacturing Units:** 10 WHO and UN recognized units
7. **R&D Team:** 406 scientists
8. **Client Base:** 1,524 clients, including 30 leading pharma companies
**IPO Highlights:**
- **Capital Raise:** Akums aims to raise over ₹1,856 crore through this IPO.
- **Growth & Expansion:** The funds will be used for capital requirements, debt repayment, and future growth.
- **Diverse Product Range:** From tablets to injections, Akums provides a wide range of pharmaceutical products.
- **Global Reach:** Serving clients in 65 countries, Akums has a strong international presence.
**Financial Insights:**
- **Revenue Growth:** Between FY22 and FY24, Akums achieved a 4% CAGR in revenue growth.
- **CDMO Market Potential:** The Indian domestic CDMO market is expected to grow at 14% CAGR between FY24 and FY28, potentially reaching $2.8 billion.
- **Client Diversity:** With a diverse base of 1,524 clients, Akums holds a 30% market share in the Indian domestic CDMO market.
- **Challenges:** The company has faced consistent negative cash flow in the last three financial years, including a ₹250 crore loss in FY22 due to fair value changes to financial instruments.
Let us know in the comments if you plan to invest in this IPO. Don't forget to subscribe to Upstox's YouTube channel for more updates and detailed analysis.
#AkumsDrugsIPO #PharmaceuticalIPO #CDMO #Investing #StockMarket #IPOAnalysis #AkumsDrugs #FinancialNews #Upstox
